Elena Schatell, PA
Physician Assistant · Eugene, ORNPI 1689300840
Payments from drug & device makers
Across 34 payments — averaging $30.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$476
- Neurocrine Biosciences, Inc.$200
- Alkermes, Inc.$142
- AbbVie$93
- Otsuka America Pharmaceutical, Inc.$29
- E.r. Squibb & Sons, L.L.C.$20
- plus $72 from 4 others
What the payments were for
- Food & beverage$82180%
- Education$21120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $476 |
| Neurocrine Biosciences, Inc. | 3 | $200 |
| Alkermes, Inc. | 3 | $142 |
| AbbVie | 1 | $93 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Organon | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$159
How this compares
$1,032 in reported general payments places this provider in the 80th percentile of 1,756 physician assistant providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium ErDivalproex Sodium | 12 | $3,003 |
| Ziprasidone Hcl | 23 | $1,592 |
| Aripiprazole | 42 | $1,255 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 37 | $955 |
| Duloxetine Hcl | 31 | $926 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $816 |
| Bupropion XlBupropion Hcl | 28 | $705 |
| Trazodone Hcl | 50 | $695 |
| Sertraline Hcl | 13 | $417 |
| Escitalopram Oxalate | 34 | $339 |
| Mirtazapine | 18 | $262 |
| Olanzapine | 12 | $247 |
| Hydroxyzine Hcl | 11 | $239 |
| Clonazepam | 30 | $198 |
| Fluoxetine Hcl | 13 | $195 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Eugene
- Devon ParksEugene$62K
- Marissa ReenEugene$15K
- Amanda VansantEugene$12K
- Eduardo ValenzuelaEugene$6K
- Amanda WeinmanEugene$6K
- Cassandra WrenEugene$6K
- Jeffrey CanterEugene$6K
- Ryan CainCorvallis$55K
- Sean BrownPortland$43K
- Pooja PatelWoodburn$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.